In a mice model of streptozotocin (STZ)-induced diabetes, THSG therapy dramatically suppressed the expression of fibronectin, CTGF, and TGF-β in kidney tissues and prevented renal injury and fibrosis (Chen et al., 2016). The gene discussed is CCN2; the disease is diabetes mellitus.